Emai£ºmarketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
Tel: +1(781)535-1428(U.S. - West Coast)
0044 7790 816 954 (Europe)
Email: marketing@medicilon.com
µØµã£ºÉϺ£ÊÐÆÖ¶«ÐÂÇø´¨ºàáé585ºÅ
Óʱࣺ201299
µç»°£º+86 (21) 5859-1500£¨×Ü»ú£©
´«Õ棺+86 (21) 5859-6369
×èÖ¹±±¾©Ê±¼ä Êý¾ÝȪԴµÚÈý·½£¬½ö¹©²Î¿¼
ÏÖʵÐÅÏ¢Çë²Î¿¼£º¶«·½²Æ²úÍø
? 2023 williamÍþÁ®ÑÇÖÞ¹Ù·½ ±£´æËùÓÐȨÁ¦ »¦ICP±¸10216606ºÅ-3
»¦¹«Íø°²±¸ 31011502018888ºÅ | ÍøÕ¾µØͼ
ÓªÒµ×Éѯ
Öйú£º
Email: marketing@medicilon.com.cn
ÓªÒµ×ÉѯרÏߣº400-780-8018
£¨½öÏÞ·þÎñ×Éѯ£¬ÆäËûÊÂÒËÇ벦´ò´¨É³×ܲ¿µç»°£©
´¨É³×ܲ¿µç»°: +86 (21) 5859-1500
ÍâÑó£º
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
Caco-2ϸ°ûÖêÊÇÈ˽᳦ÏÙ°©ÉÏƤϸ°û£¬¿ÉÒÔ×ÔÐзֽâΪÀàËÆÈ˳ÉÊìµÄС³¦ÉÏƤϸ°ûµ¥²ã¡£¾ÓÉÑо¿·¢Ã÷Caco-2ϸ°û»¹Äܱí´ï°üÀ¨ÌÇ£¬°±»ùËᣬµ¨ÖËáÒÔ¼°P¡ªgpºÍMRPsµÈתÔËÔØÌ壬Òò´ËCaco-2ϸ°ûÒѾ³ÉΪÑо¿Ò©Îï±»¶¯¼°×Ô¶¯×ªÔËÎüÊÕµÄÄ£×Ó¡£
£¨1£©Ñª½¬ÂÑ°×ÍŽáÊÔÑ飨PPB£©£ºÔÚ2014°æ¡¶ÁÙ´²Ç°Ò©´úÖ¸µ¼ÔÔò¡·ÖÐÓÐÃ÷È·»®¶¨£¬ÊÔÑéÉè¼ÆÖÐN=3£¬ÐèÒª¹ØעŨ¶ÈÒÀÀµÐÔºÍÖÖÊô²î±ð£»
£¨2£©ÌåÍâ´úл£¨Metabolic stability/MetID£©£º¹Ø×¢ÖÖÊô²î±ð£¬ÎªÌåÄÚPK¼°¶¾Àí¡¢ÖÖÊôµÄÑ¡ÔñÌṩ²Î¿¼£»
£¨3£©ÌåÍâDDI£ºP450ÒÖÖÆ£¬P450ÓÕµ¼£¨Êý¾ÝÆÊÎö²Î¿¼FDA Guidance£ºDDI 2006 DraftºÍ2020 In Vitro DDI£©£¬Ã¸±íÐÍCYP/Non-CYP´úл;¾¶Åжϣ»
£¨4£©×ªÔËÌåÑо¿£¨Transporter substrate assessment & inhibition£©£ºCaco-2, P-gp, BCRP, OATP1B1, OATP1B3, OAT1, OAT3, OCT2¡£
£¨1£©Noncompartmental Analysis ·Ç·¿ÊÒÄ£×Ó£¬½ÏΪΪÇáÓ¯¿Í¹Û,Ëù»ñ²ÎÊý(t1/2¡¢Vd¡¢CL¡¢Cmax¡¢Tmax¡¢MRT¡¢AUC0-t¡¢AUC0-¡ÞµÈ)ÇкÏINDÉ걨ҪÇó,²»¿ÉÓÃÓÚÕ¹ÍûºÍÄ£Äâ,»ùÓÚÏßÐÔPK¼ÙÉè;
£¨2£©Traditional Compartmental PK Model ¾µä·¿ÊÒÄ£×Ó£¬Ïà¶Ô¼òÆÓÒ×ÐУ¬¿ÉÄâºÏ·ÇÏßÐÔPKÊý¾Ý,¿ÉÓÃÓÚÕ¹ÍûºÍÄ£Äâ,×ÊÖúÊÔÑéÉè¼Æ£»
£¨3£©Population PK Model ȺÌåÒ©´úÄ£×Ó£¬ÁÙ´²Ç°Ê¹ÓýÏÉÙ£¬¸üÊʺÏÏ£º±Êý¾Ý¼°Ð±äÁ¿ÆÊÎö( NONMEM/Monolix)¡£
£¨1£©20ÄêÂÄÀú»ýÀÛ£»
£¨2£©Ã¿ÄêÍê³ÉÔ¼20¸öÐÂÒ©µÄÁÙ´²Ç°DMPKÉ걨Ñо¿£»
£¨3£©Ã¿Äê´óÓÚ2000¸ö»¯ºÏÎïµÄÌåÄÚPKɸѡ£»
£¨4£©PK/PDһվʽ·þÎñ£»
£¨5£©¿¹Ìå/ADCÁÙ´²Ç°DMPK·þÎñ£»
£¨6£©Í¬Î»ËØÒ©´úÑо¿×¨ÒµÊÖÒÕƽ̨¡£